Abstract
To identify the clinical and radiological features distinguishing Mycobacterium simiae respiratory infection from pulmonary tuberculosis, the demographics, underlying conditions, and clinical and radiological findings of 121 consecutive patients with pulmonary tuberculosis and 102 with M. simiae respiratory infection were compared retrospectively. In the M. simiae group, the patients were older (mean age 69 ± 16 years vs. 47 ± 21 years, p = 0.0001), with a female predominance (62% vs. 45%, p = 0.008). Only 4% were of Ethiopian origin compared to 25% of the tuberculosis group (p = 0.0001). M. simiae infection was associated with significantly higher rates of smoking history, underlying chronic obstructive pulmonary disease, zero human immunodeficiency virus (HIV) infection compared to 10% in the tuberculosis group (p = 0.001), blunted symptoms, and noncavitary infiltrates in the lower/middle lobes on chest X-ray. HIV-negative patients with M. simiae respiratory infection are distinguishable from patients with pulmonary tuberculosis by several demographic, clinical, and radiological features. These findings have important diagnostic and therapeutic implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Samra Z, Kaufman L, Pitlik S, Shalit I, Bishara J (2005) Emergence of Mycobacterium simiae in respiratory specimens. Scand J Infect Dis 37:838–841
El Sahly HM, Septimus E, Soini H, Septimus J, Wallace RJ, Pan X, Williams-Bouyer N, Musser JM, Graviss EA (2002) Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 35:802–807
Bell RC, Higichi JH, Donovan WN, Krasnow I, Johanson WG Jr (1983) Mycobacterium simiae. Clinical features and follow-up of twenty-four patients. Am Rev Respir Dis 127:35–48
Huminer D, Dux S, Samra Z, Kaufman L, Lavy A, Block CS, Pitlik SD (1993) Mycobacterium simiae infection in Israeli patients with AIDS. Clin Infect Dis 17:508–509
Valero G, Peters J, Jorgensen JH, Graybill JR (1995) Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med 152:1555–1557
Evans SA, Colville A, Evans AJ, Crisp AJ, Johnston ID (1996) Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 51:1248–1252
Wallace RJ, Glassroth J, Griffith DE, Olivier KN, Cook J, Gordin F (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. The American Thoracic Society Guidelines. Am J Respir Crit Care Med 156:S1–S25
Notle FS, Metchock B (1995) Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 400–437
Kent PT, Kubica GP (1985) Public health mycobacteriology. A guide for the level III laboratory. Department of Health and Human Services, Centers for Disease Control, Atlanta, GA
American Thoracic Society (2003) Treatment of tuberculosis. Am J Respir Crit Care Med 167:603–662
Shitrit D, Priess R, Peled N, Bishara G, Shlomi D, Kramer MR (2007) Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis 26:679–684
O’Brien RJ, Geiter LJ, Snider DE Jr (1987) The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 135:1007–1014
Centers for Disease Control and Prevention (CDC) (1999) Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories: United States, 1993–1996. cdc.gov/ncidod/dastlr/mycobacteriology.htm (no longer available). Accessed July 1999
Al-Abdely HM, Revankar SG, Graybill JR (2000) Disseminated Mycobacterium simiae infection in patients with AIDS. J Infect 41:143–147
Griffith DE, Girard WM, Wallace RJ Jr (1993) Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147:1271–1278
Griffith DE, Brown-Elliott BA, Wallace RJ Jr (2003) Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 37:1178–1182
Barzilai A, Rubinovich B, Blank-Porat D, Rubinstein E, Keller N, Levi I (1998) Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients. Scand J Infect Dis 30:143–146
Valero G, Moreno F, Graybill JR (1994) Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. Antimicrob Agents Chemother 38:2676–2677
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maoz, C., Shitrit, D., Samra, Z. et al. Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 27, 945–950 (2008). https://doi.org/10.1007/s10096-008-0522-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-008-0522-6